Decas Earns Cranberry Patent for Controlling Metabolic Syndrome
The company now holds 10 worldwide cranberry ingredient patents.
Decas Botanical Synergies LLC (Carver, MA) has secured a cranberry-based patent, U.S. patent #8,173,178, for controlling metabolic syndrome. The patent is labeled “Compositions and methods for controlled metabolic syndrome using whole fruit-derived cranberry ingredient profile enriched in stress adopted bioactives (SABs).”
“We look forward to partnering with leading nutritional supplement and healthcare providers to penetrate the market for natural cranberry-based solutions for controlling metabolic syndrome,” said Dan Souza, senior director of sales and marketing at Decas Botanical. “This patent, coupled with out published work linking cranberry to prostate health, illustrates DBS’ commitment to expanding the cranberry market beyond prevention of urinary tract infections.”
Decas now holds 10 worldwide patents for cranberry ingredients.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Steve Mister on CRN's ongoing lawsuit against New York State
October 11th 2024Nutritional Outlook spoke to The Council for Responsible Nutrition's president and CEO, Steve Mister, at its annual meeting, Convergence '24. Mister discussed the latest in its ongoing lawsuit against NY State's law banning the sale of weight management and muscle building products to minors.
